Medtronic on Nov. 16 completed the acquisition of Medicrea, a France-based spine device company.
Four things to know:
1. Medicrea specializes in artificial intelligence, predictive modeling and patient-specific implants.
2. The transaction bolsters Medtronic's expansion into AI, machine learning and predictive analytics.
3. The company has more than 30 implants that have received CE Mark or FDA approval. The products are designed for spinal deformity and degenerative disc disease.
4. Terms of the transaction were not disclosed.